Cyril Kahn

Cyril Kahn is a Lecturer at University of Lorraine with extensive research in nanoliposome technology and biomaterials development. His work bridges pharmaceutical sciences, tissue engineering, and biomedical applications with a particular focus on drug delivery systems.

His primary research interests include Nanoliposome Technology, Drug Delivery Systems, Tissue Engineering, and Biomaterials Development. Kahn's research demonstrates significant innovation in creating targeted delivery systems for neuroprotective agents, particularly using curcumin and other natural compounds. His work on GelMA hydrogels and 3D printing represents cutting-edge approaches to scaffold development for tissue regeneration.

Analysis of his recent publications (2023-2025) reveals a strong emphasis on

• Nanoliposome functionalization for targeted drug delivery
• Advanced hydrogel systems for tissue engineering
• Multiscale biomaterial design incorporating natural compounds
• Microfluidic platforms for drug testing
• Sustainable biomaterial processing techniques

Kahn's research shows consistent progression toward more complex, multi-functional biomaterial systems with therapeutic applications.

His technical expertise spans nanoliposome formulation, hydrogel characterization, 3D bioprinting, and in vitro testing of biomaterials. The interdisciplinary nature of his work connects pharmaceutical sciences with tissue engineering and materials science.